ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics

BACKGROUND: Triple negative breast cancer (TNBC) is the most lethal subtype of breast cancer due to its aggressive behavior and frequent development of resistance to chemotherapy. Although natural killer (NK) cell-based immunotherapy is a promising strategy for overcoming barriers to cancer treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Joo Dong, Kim, Kwang-Soo, Choi, Seung Hee, Jo, Gae Hoon, Choi, Jin-Ho, Park, Si-Won, Ko, Eun-Su, Lee, Minwook, Lee, Dae-Keum, Jang, Hye Jung, Hwang, Sohyun, Jung, Hae-Yun, Park, Kyung-Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305827/
https://www.ncbi.nlm.nih.gov/pubmed/35858708
http://dx.doi.org/10.1136/jitc-2022-004825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305827/
https://www.ncbi.nlm.nih.gov/pubmed/35858708
http://dx.doi.org/10.1136/jitc-2022-004825

Ejemplares similares